@skarim01 @netta_doc There was a recent publication showing use of telellmetey for inpatients using biotel monitors. However home loading could be problematic due to risk of ventricular arrhythmias and no immediate treatment available. https://t.co/dE9PB
Finally out in hard copies! It’s a quick read. Check out how we overcame #COVID19 in New York. Small community hospitals with limited telemetry capacities may benefit the most by using our strategy as new cases surge around the country. https://t.co/p4h1J
Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin. https://t.co/BN3fkFNlfW
RT @navarro_fm: 📉Datos 🗓13/06/20 #CoronavirusESP en C. Valenciana: 🤒4 nuevos casos ✅106Altas 🖤2 fallecimientos Totales: 🤒14541contagios ✅…
RT @navarro_fm: 📉Datos 🗓13/06/20 #CoronavirusESP en C. Valenciana: 🤒4 nuevos casos ✅106Altas 🖤2 fallecimientos Totales: 🤒14541contagios ✅…
RT @navarro_fm: 📉Datos 🗓13/06/20 #CoronavirusESP en C. Valenciana: 🤒4 nuevos casos ✅106Altas 🖤2 fallecimientos Totales: 🤒14541contagios ✅…
📉Datos 🗓13/06/20 #CoronavirusESP en C. Valenciana: 🤒4 nuevos casos ✅106Altas 🖤2 fallecimientos Totales: 🤒14541contagios ✅13296curados 🖤1549 fallecimientos 👉🏽Imagen: Telemonitorización cardíaca en 💊domiciliario en #COVID19 vía: @JACCJournals 🔗https://t.
Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin | JACC: Journal of the American College of Cardiology https://t.co/QuEwyG6vdF
RT @kdjhaveri: Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithro… https:/…
Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithro… https://t.co/O8k4gfxo8X
@NAChristakis @JAMACardio Just accepted @JACC article by David Chang reveals how hospitals that are treating patients w/ #HCQ efficaciously can adapt MCOT mobile telemetry to deal with the reactions quickly when they do occur. (28 urgent alerts over ~ 300
Initial study of #COVID19 patients treated with hydroxychloroquine (HCQ) and/or azithromycin (AZM) from @NorthwellHealth published in #JACC demonstrate critical need for continuous near-real time monitoring of the heart. Read study https://t.co/zbPyfLeWLL
Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin | JACC: Journal of the American College of Cardiology https://t.co/nSVWIY7Y9c
RT @schneiderleonid: "28 “urgent alerts” were communicated in near real-time to an electrophysiologist, of which 16 alerts resulted in mana…
Great. We previously showed that the QT prolongation may be a harbinger of acute ACF in MI. More information at Researchgate. Inpatient Use of Ambulatory TelemetrMonitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin https://t.c
@philippefroguel @fignon_laurent @ZeClint @Fraslin @DrGomi Le pragmatisme américain dans ses œuvres. Si les études double blind & randomized sèment simultanément pluie et beau temps ds qques jours, ils sauront s'adapter au quart de tour. Eux. https:
RT @JamesGabriels: @d_changy @hisbundle
@d_changy @hisbundle
@NorthwellHealth research published in #JACC demonstrates inpatient use of MCOT™ to monitor arrythmias and assess the QTc of #COVID19 patients treated with hydroxychloroquine (HCQ) and/or azithromycin (AZM). View research: https://t.co/Aqt43xVSha https://t
Excellent informative study @JACCJournals #medtwitter 1️⃣ 34% on QT prolonging meds=check @CredibleMeds (https://t.co/t23qZNACol) 2️⃣ AF is common=for QTc calculation in AF we built an online tool. https://t.co/wwhrZ8V4Ur 3️⃣ 4% had QTc>500= #RespectThe